Author

Eriko Kunikane

Observed names: Eriko KUNIKANE, Kunikane Eriko, Kunikane, Eriko

Institution: Senju Pharmaceutical (Japan)

Observed institutions: Senju Pharmaceutical (Japan), Showa Pharmaceutical University

ORCID: 0000-0002-4742-9459

Observed ORCID: 0000-0002-4742-9459

OpenAlex ID: A5011551992

Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs

2020 · Gen Suzuki, Eriko Kunikane, et al. · Ophthalmology and Therapy · 28

Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

2023 · Yasuo Yanagi, Kanji Takahashi, et al. · Ophthalmology and Therapy · 26

Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations

2020 · Gen Suzuki, Eriko Kunikane, et al. · Current Eye Research · 9

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study

2022 · Yusuke Orii, Eriko Kunikane, et al. · PLoS ONE · 6

Human Plasma Concentrations of Tolbutamide and Acetaminophen Extrapolated from in vivo Animal Pharmacokinetics Using in vitro Human Hepatic Clearances and Simple Physiologically Based Pharmacokinetic Modeling for Radio-labeled Microdose Clinical Studies

2015 · Hiroshi YAMAZAKI, Eriko KUNIKANE, et al. · RADIOISOTOPES · 6

The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits

2023 · Nana Takahashi, Kota Sato, et al. · PLoS ONE · 4

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study

2023 · Yusuke Orii, Eriko Kunikane, et al. · Journal of Clinical Medicine · 3

Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis

2023 · Eriko Kunikane, Yusuke Orii, et al. · Ophthalmology and Therapy · 2

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

2023 · Yasuo Yanagi, Kanji Takahashi, et al. · Ophthalmology and Therapy · 1

新薬の紹介 α 2 作動薬/炭酸脱水酵素阻害薬配合剤緑内障・高眼圧症治療剤ブリモニジン酒石酸塩・ブリンゾラミド配合懸濁性点眼液(アイラミド配合懸濁性点眼液)

2020 · Kunikane Eriko · 日本病院薬剤師会雑誌

Works count: 11

Citation count: 85

H-index: 5

I10-index: 2